Thermo Fisher Scientific Operating Margin 2010-2022 | TMO

Current and historical operating margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current operating profit margin for Thermo Fisher Scientific as of December 31, 2022 is 20.39%.
Thermo Fisher Scientific Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-12-31 $44.92B $8.39B 18.69%
2022-09-30 $44.17B $9.07B 20.54%
2022-06-30 $42.82B $9.64B 22.51%
2022-03-31 $41.12B $9.80B 23.83%
2021-12-31 $39.21B $10.03B 25.57%
2021-09-30 $39.06B $10.56B 27.04%
2021-06-30 $38.25B $10.71B 28.00%
2021-03-31 $35.89B $9.94B 27.68%
2020-12-31 $32.22B $7.79B 24.19%
2020-09-30 $28.50B $5.96B 20.90%
2020-06-30 $26.25B $4.48B 17.05%
2020-03-31 $25.65B $4.58B 17.86%
2019-12-31 $25.54B $4.59B 17.99%
2019-09-30 $25.22B $4.51B 17.88%
2019-06-30 $24.87B $4.48B 18.00%
2019-03-31 $24.63B $3.92B 15.90%
2018-12-31 $24.36B $3.78B 15.53%
2018-09-30 $23.90B $3.59B 15.03%
2018-06-30 $23.09B $3.31B 14.35%
2018-03-31 $22.01B $3.13B 14.21%
2017-12-31 $20.92B $2.96B 14.15%
2017-09-30 $19.82B $2.76B 13.94%
2017-06-30 $19.20B $2.67B 13.91%
2017-03-31 $18.74B $2.56B 13.66%
2016-12-31 $18.27B $2.46B 13.45%
2016-09-30 $17.97B $2.39B 13.28%
2016-06-30 $17.61B $2.41B 13.68%
2016-03-31 $17.34B $2.37B 13.65%
2015-12-31 $16.97B $2.34B 13.77%
2015-09-30 $16.81B $2.29B 13.60%
2015-06-30 $16.85B $2.36B 14.01%
2015-03-31 $16.91B $2.11B 12.51%
2014-12-31 $16.89B $2.50B 14.82%
2014-09-30 $15.86B $2.32B 14.62%
2014-06-30 $14.89B $2.07B 13.91%
2014-03-31 $13.80B $2.10B 15.20%
2013-12-31 $13.09B $1.61B 12.29%
2013-09-30 $12.88B $1.56B 12.07%
2013-06-30 $12.78B $1.52B 11.86%
2013-03-31 $12.65B $1.51B 11.93%
2012-12-31 $12.51B $1.48B 11.85%
2012-09-30 $12.30B $1.43B 11.62%
2012-06-30 $12.15B $1.39B 11.47%
2012-03-31 $11.90B $1.29B 10.85%
2011-12-31 $11.56B $1.25B 10.81%
2011-09-30 $11.05B $1.21B 10.90%
2011-06-30 $10.75B $1.19B 11.09%
2011-03-31 $10.49B $1.23B 11.68%
2010-12-31 $10.39B $1.19B 11.44%
2010-09-30 $10.49B $1.16B 11.08%
2010-06-30 $10.40B $1.14B 10.93%
2010-03-31 $10.28B $1.10B 10.67%
2009-12-31 $9.91B $1.00B 10.11%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $230.517B $44.915B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00